The Biden-Harris administration’s U.S. Food and Drug Administration (FDA) has given the green light to advance a new “self-amplifying” mRNA “vaccine” for “bird flu.”
The new “vaccine” is being developed by Arcturus Therapeutics, a Bill Gates-funded company specializing in mRNA-based pharmaceuticals.
On Monday, Arcturus quietly announced that the FDA approved the company’s Investigational New Drug (IND) application for its ARCT-2304 “vaccine.”
ARCT-2304 is a self-amplifying mRNA (sa-mRNA) injection targeting the H5N1 avian influenza “bird flu” virus.
The “self-amplifying” or “replicon” mRNA shots contain the equipment needed to make more of itself once it enters cells.
